Log In
BCIQ
Print this Print this
 

AGT-184

  Manage Alerts
Collapse Summary General Information
Company ArmaGen Inc.
Description 
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationMucopolysaccharidosis
Indication DetailsTreat mucopolysaccharidosis IIIA (MPS IIIA, Sanfilippo A syndrome)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today